Board Meeting12 Oct 2026, 03:48 pm
Nephrocare Health Services Ltd Board Meeting on Nov 3, 2026
AI Summary
Nephrocare Health Services Ltd has announced a Board of Directors meeting scheduled for November 3, 2026. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. Consequently, the trading window for designated persons and their immediate relatives will remain closed from October 1, 2026, to November 5, 2026, inclusive.
Key Highlights
- Board meeting scheduled for November 3, 2026.
- Agenda includes approval of Q2 FY27 financial results.
- Unaudited standalone and consolidated results to be reviewed.
- Trading window closed from October 1 to November 5, 2026.
Price Impact
More from NEPHROPLUS